Catalog No.: PC-20678Not For Human Use, Lab Use Only.
AB-836 is a next generation oral hepatitis B virus (HBV) capsid inhibitor with HepDE19 EC50 of 10 nM, interacts with HBV core protein and demonstrates robust antiviral activity.
AB-836 is a next generation oral hepatitis B virus (HBV) capsid inhibitor with HepDE19 EC50 of 10 nM, interacts with HBV core protein and demonstrates robust antiviral activity.
AB-836 in combination with nucleos(t)ide analogues is designed to completely eliminate viral replication in infected cells by preventing the assembly of functional viral capsids.
AB-836 has been shown to inhibit the replenishment of covalently closed circular DNA (cccDNA), the viral genetic reservoir which the virus needs to replicate itself.
